New York State Common Retirement Fund
CYT

New York State Common Retirement Fund’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

New York State Common Retirement Fund’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-189
Closed -$1K – 3509
2022
Q2 		$1K Sell
189
-5,789
-97% -$14.8K ﹤0.01% 3445
2022
Q1 		$23K Buy
5,978
+7
+0.1% +$40 ﹤0.01% 3280
2021
Q4 		$68K Buy
+5,971
New +$91K ﹤0.01% 3165

Other funds holding CYT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's CYT Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q3 2022, closing a stake of 189 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in CYT in Q4 2021 and held it in 3 quarters. The position peaked at $68K in Q4 2021. 37 funds tracked by Wall St. Rank hold CYT as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 189 Cyteir Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • New York State Common Retirement Fund first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • New York State Common Retirement Fund's Cyteir Therapeutics, Inc. Common Stock position peaked at $68K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.